Faron Pharmaceuticals OY (FARN) NPV
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
No change
59.00p
59.95p
840.00p
£20.93 million
59.00p
58.15p
51.00p
n/a
0.00p (0.00%) Previous:
0.00p
3,363
n/a
5,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2017 | 31/12/2016 |
|---|---|---|
| Revenue (€m) | n/a | 0.95 |
| Profit before tax (€m) | (21.06) | (10.06) |
| Adjusted EPS (¢): | (76.00) | (42.00) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: Euro
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Open an easy to manage, low cost dealing account in less than 5 minutes
Deal shares from just £11.95 per trade online, and as low as £5.95 per trade for active traders.
More about the Fund and Share AccountImportant Documents
There are no documents available for this stock.
Broker forecasts
Broker recommendations for this stock are not available.
-
Faron Pharmaceuticals upbeat on latest info from MATINS trial
11 April 2019 11:22
-
Faron Pharmaceuticals shares surge on latest Clevegen data
21 February 2019 10:09
-
Faron Pharmaceuticals pins some hope to YODA trial
19 December 2018 11:07
-
Holding(s) in Company
25 April 2019 16:09
-
Holding(s) in Company
12 April 2019 13:20
-
First expansion cohort for MATINS trial part 2
11 April 2019 07:00
| Time / date Time | Buy / sell Type | Volume | Price | Value |
|---|
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled ‘N/A’.
Annual & interim reports
Annual & interim reports are not available for this stock.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.